MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN

被引:54
作者
Yan, Shi-yan [1 ]
Chen, Mei-mei [1 ]
Li, Guang-ming [1 ]
Wang, Yu-qin [1 ]
Fan, Jian-gao [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gastroenterol, Shanghai 200030, Peoples R China
基金
中国国家自然科学基金;
关键词
miR-32; PTEN; Signaling pathway; Hepatocellular carcinoma; LIVER-CANCER; UP-REGULATION; EXPRESSION; MICRORNAS; CYCLE; EZH2;
D O I
10.1007/s13277-015-3124-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) regulate gene expression by inhibiting translation of target messenger RNAs (mRNAs) through pairing with miRNA recognition elements (MREs), usually in 3'-UTRs. miRNAs are involved in the pathogenesis of several types of cancers. Specifically, microRNA-32 (miR-32) is overexpressed in colorectal carcinoma, wherein accumulating evidence indicates that it functions as an oncogene. However, the function of miR-32 in hepatocellular carcinoma (HCC) has not been totally elucidated. In the present study, we found the expression of miR-32 was up-regulated in HCC tissue and cell lines, inversely the expression of phosphatase and tensin homolog (PTEN) decreased. Besides, miRNA-32 down-regulates PTEN through binding to 3'-UTR of PTEN mRNA from luciferase reporter assay, and the expression level of miR-32 could affect the proliferation, migration, and invasion of liver cancer cell lines via PTEN/Akt signaling pathway. Down-expression of PTEN could significantly attenuate the inhibitory effects of knockdown miR-32 on the proliferation, migration, and invasion of liver cancer cells, suggesting that miR-32 could be a potential target for HCC treatment.
引用
收藏
页码:4747 / 4755
页数:9
相关论文
共 28 条
  • [1] MicroRNAs: Target Recognition and Regulatory Functions
    Bartel, David P.
    [J]. CELL, 2009, 136 (02) : 215 - 233
  • [2] MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells
    Dang, Xiaomin
    Ma, Aiqun
    Yang, Lan
    Hu, Hao
    Zhu, Bo
    Shang, Dong
    Chen, Tianjun
    Luo, Yu
    [J]. CANCER GENETICS, 2012, 205 (03) : 113 - 123
  • [3] Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
    El-Serag, Hashem B.
    Rudolph, Lenhard
    [J]. GASTROENTEROLOGY, 2007, 132 (07) : 2557 - 2576
  • [4] MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma
    Fang, YuXiang
    Xue, Jing-Lun
    Shen, Qi
    Chen, Jinzhong
    Tian, Ling
    [J]. HEPATOLOGY, 2012, 55 (06) : 1852 - 1862
  • [5] Garzon R, 2009, ANNU REV MED, V60, P167, DOI [10.1146/annurev.med.59.053006.104707, 10.1146/annurev.pathol.4.110807.092222]
  • [6] Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer
    Gong, Chang
    Yao, Yandan
    Wang, Ying
    Liu, Bodu
    Wu, Wei
    Chen, Jianing
    Su, Fengxi
    Yao, Herui
    Song, Erwei
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (21) : 19127 - 19137
  • [7] Cytotoxicity of Voriconazole on Cultured Human Corneal Endothelial Cells
    Han, Sang Beom
    Shin, Young Joo
    Hyon, Joon Young
    Wee, Won Ryang
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (10) : 4519 - 4523
  • [8] Micrornas: Small RNAs with a big role in gene regulation
    He, L
    Hannon, GJ
    [J]. NATURE REVIEWS GENETICS, 2004, 5 (07) : 522 - 531
  • [9] Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma
    Hou, Jin
    Lin, Li
    Zhou, Weiping
    Wang, Zhengxin
    Ding, Guoshan
    Dong, Qiongzhu
    Qin, Lunxiu
    Wu, Xiaobing
    Zheng, Yuanyuan
    Yang, Yun
    Tian, Wei
    Zhang, Qian
    Wang, Chunmei
    Zhang, Qinghua
    Zhuang, Shi-Mei
    Zheng, Limin
    Liang, Anmin
    Tao, Wenzhao
    Cao, Xuetao
    [J]. CANCER CELL, 2011, 19 (02) : 232 - 243
  • [10] Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer
    Jalava, S. E.
    Urbanucci, A.
    Latonen, L.
    Waltering, K. K.
    Sahu, B.
    Janne, O. A.
    Seppala, J.
    Lahdesmaki, H.
    Tammela, T. L. J.
    Visakorpi, T.
    [J]. ONCOGENE, 2012, 31 (41) : 4460 - 4471